FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 65326

News▼ Bearish

An officer and director proposes selling 560,000 shares of ImmunityBio (NASDAQ: IBRX).

KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-05 14:22 UTC
LAST UPDATE2026-10-05 14:22 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

An officer's proposed share sale adds supply and can signal insider caution, pressuring the stock short term.

Insider selling signals caution at ImmunityBio
CATALYST TO WATCH

Actual sale execution and size

MAIN RISK

Proposal may not be fully executed

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01googlenewsnews.google.com · PRIMARY2026-10-05 14:22 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares Healthcare
What We’re Thinking: A Democratic Senate Takeover? Maybe, Maybe Not
2026-10-05 14:25 UTC
→CORRELATIONshares Healthcare
AI in Protein Engineering Market worth $3.82 billion by 2031
2026-10-05 14:30 UTC
→CORRELATIONshares Healthcare
I got a $499 body scan to see if I have cancer. Here’s what I learned.
2026-10-05 14:35 UTC
→CORRELATIONshares Healthcare
TRex Bio files for 8.33M share IPO at $14-$16/sh
2026-10-05 10:50 UTC
→CORRELATIONshares Healthcare
TRex Bio Files for Nasdaq IPO - Yahoo! Finance Canada
2026-10-05 14:06 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.